Home / Locations / Prague


Czech Republic

CMS was among the first foreign law firms to open in the Czech Republic. Building on more than 25 years of experience in the local market, we offer our clients extensive expertise and knowledge of the local legal and commercial landscape.

We have a team of over 40 Czech and internationally qualified lawyers based in our Prague office. Whether you plan to conduct a transaction or conclude a commercial agreement under Czech or English law, we have the resources available ‘on the ground’ to staff it locally.

We pride ourselves on the fact that many our transactional clients retain us for on-going legal work and more strategic projects for many years after the initial instruction. Located in modern offices in the city centre our clients are welcome to work in our meeting rooms when in Prague and make the most of our client services. 

If you need support in the Czech Republic, be it on the expansion of your business through an acquisition or a greenfield investment, complex regulatory issues or your day-to-day operations, please contact one of our team.

more less


By foot

Walk along the street, Na Poříčí, that runs down the right-hand side of the Palladium Shopping Centre (whilst facing it), keeping on the left-hand pavement.

Just past the tram/bus stop, enter the first set of gates you come to on your left. A small blue plaque marks this entrance number 3a.

Turn immediately right into the building lobby.

Sign in with the receptionist, who will give you a card that operates the turnstiles.

Proceed to the lifts and take a lift to the third floor.

Upon exiting the lift, turn right then immediately left and follow the signs to CMS Cameron McKenna.

Go through the double doors and turn right at the end of the corridor.

Our reception is in front of you. Press the buzzer to be admitted.

more less


CMS Cameron McKenna Nabarro Olswang, advokáti, v.o.s.
Palladium, Na Poříčí 1079/3a
110 00 Prague 1
Czech Republic
Directions PDF Open Google Maps


Show only
01 March 2021
The Glob­al Sul­phur Ban – One Year On
Since 1 March 2020 all mar­ine ves­sels have been sub­ject to a ban from car­ry­ing on board high sul­phur mar­ine fuel oil (“HSFO”) with sul­phur con­tent great­er than 0.50% un­less they have a ‘scrub­ber’...
24 February 2021
COV­ID and ViCo: EPO re­fer­ral to the En­larged Board of Ap­peal
In the last year, the COV­ID-19 pan­dem­ic has res­ul­ted in a large pro­por­tion of the leg­al sec­tor trans­ition­ing to a ‘work from home’ ar­range­ment, with meet­ings tak­ing place re­motely. Non-es­sen­tial travel...
22 February 2021
Czech Re­pub­lic ap­proves new rules for ad­vert­ising med­ic­al devices
On 16 Feb­ru­ary 2021, the Czech pres­id­ent signed the new law, which amends the Ad­vert­ise­ment Act and in­tro­duces new rules on the ad­vert­ising of med­ic­al devices. As re­por­ted in our Law-Now pub­lished...
19 February 2021
EU Gen­er­al Court dis­misses Ry­anair's ac­tions against French and Swedish...
On 17 Feb­ru­ary 2021, the Gen­er­al Court con­firmed the leg­al­ity of the European Com­mis­sion's de­cisions ap­prov­ing the French and Swedish aid schemes in fa­vour of their air­lines. These two schemes, in­tro­duced...
18 February 2021
Changes to the Czech Act on Busi­ness Cor­por­a­tions - New rules re­gard­ing...
On 1 Janu­ary 2021, an Amend­ment to the Czech Act on Busi­ness Cor­por­a­tions came in­to ef­fect, which in­tro­duced changes in the area of cor­por­ate gov­ernance. These in­clude changes to the li­ab­il­ity of stat­utory...
17 February 2021
CMS Ex­pert Guide to com­puls­ory li­cens­ing
In­tel­lec­tu­al prop­erty rights are crit­ic­al for any eco­nomy that wants to foster a cul­ture of in­nov­a­tion, risk tak­ing, and en­tre­pren­eur­ship. Par­tic­u­larly in a med­ic­al con­text, phar­ma­ceut­ic­al com­pan­ies...
16 February 2021
Fight­ing poor med­ic­a­tion ad­her­ence in the European Uni­on: The Grav­it­ate-Health...
Nowadays, European cit­izens can ob­tain a great amount of in­form­a­tion (on­line and off­line) about any medi­cine. However, this in­form­a­tion is in many cases un­re­li­able and dif­fi­cult to un­der­stand, en­cour­aging...
12 February 2021
‘It’s like milk but made for hu­mans’: Gen­er­al Court over­turns EUIPO’s re­fus­al...
On 20 Janu­ary 2021, the Gen­er­al Court (“GC”) handed down its judg­ment in the ap­peal brought by Oatly AB (“Oatly”) against the de­cision of the EU In­tel­lec­tu­al Prop­erty Of­fice (“EUIPO”) to re­fuse...
11 February 2021
Anti-coun­ter­feit­ing and Il­li­cit Trade
Des­pite COV­ID-19 vac­cines be­ing only a few months old, we are already see­ing the con­fis­ca­tion of coun­ter­feit vac­cines and the il­li­cit trade of genu­ine vac­cines. For those in the life sci­ences and health...
11 February 2021
New EPO Guidelines now pub­lished re­gard­ing amend­ing the de­scrip­tion: what’s...
In­tro­duc­tion In Oc­to­ber 2020, CMS pub­lished an art­icle ‘New EPO Guidelines ex­pec­ted re­gard­ing amend­ing a de­scrip­tion: what’s all the fuss about?’, which has been the cata­lyst for dis­cus­sion in the...
09 February 2021
BAT con­clu­sions for large com­bus­tion plants an­nulled – What next?
On 27 Janu­ary 2021 the Gen­er­al Court of the European Uni­on de­clared the so-called BAT con­clu­sions for large com­bus­tion plants an­nulled. It is worth con­sid­er­ing what this rul­ing really means and what it...
03 February 2021
Ex­ten­sion of the Tem­por­ary Frame­work on state aid and COV­ID-19
The Tem­por­ary Frame­work ad­op­ted by the European Com­mis­sion in March 2020 is based on Art­icle 107(3)(b) TFEU  to rem­edy a ser­i­ous dis­turb­ance across the EU eco­nomy. Only com­pan­ies that en­countered dif­fi­culties...